Celsion’s Phase I/II ovarian cancer trial completes subject enrolment

Celsion’s Phase I/II ovarian cancer trial completes subject enrolment

Submitted by admin on September 16, 2022 - 10:14am
Source: 
Clinical Trials Arena
News Tags: 
Celsion
ovarian cancer
GEN-1
clinical trials
Headline: 
Celsion’s Phase I/II ovarian cancer trial completes subject enrolment
snippet: 

Celsion has concluded subject enrolment in the Phase I/II OVATION 2 Study of its IL-12 gene-mediated immunotherapy, GEN-1, in advanced ovarian cancer patients.

Do Not Allow Advertisers to Use My Personal information